Dynamic Technology Lab Private Ltd Acquires New Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Dynamic Technology Lab Private Ltd acquired a new position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 51,056 shares of the company's stock, valued at approximately $813,000. Dynamic Technology Lab Private Ltd owned 0.11% of Avanos Medical at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tributary Capital Management LLC raised its holdings in Avanos Medical by 38.1% in the 4th quarter. Tributary Capital Management LLC now owns 893,008 shares of the company's stock valued at $14,217,000 after acquiring an additional 246,379 shares in the last quarter. JPMorgan Chase & Co. raised its position in Avanos Medical by 189.8% in the 4th quarter. JPMorgan Chase & Co. now owns 201,634 shares of the company's stock worth $3,210,000 after purchasing an additional 132,063 shares during the last quarter. Norges Bank bought a new position in shares of Avanos Medical in the 4th quarter valued at about $1,664,000. Empowered Funds LLC boosted its holdings in Avanos Medical by 141.3% during the fourth quarter. Empowered Funds LLC now owns 153,834 shares of the company's stock worth $2,449,000 after buying an additional 90,091 shares during the last quarter. Finally, Barclays PLC raised its holdings in Avanos Medical by 446.2% in the third quarter. Barclays PLC now owns 96,194 shares of the company's stock worth $2,311,000 after purchasing an additional 78,583 shares during the period. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Avanos Medical Stock Performance

AVNS stock traded down $0.12 during mid-day trading on Friday, hitting $12.31. 83,370 shares of the company were exchanged, compared to its average volume of 322,230. Avanos Medical, Inc. has a 1-year low of $12.09 and a 1-year high of $25.36. The stock has a market capitalization of $566.30 million, a PE ratio of 36.16 and a beta of 1.15. The business has a 50 day simple moving average of $14.96 and a 200-day simple moving average of $17.57. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

Avanos Medical (NYSE:AVNS - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. The company had revenue of $179.60 million for the quarter, compared to analyst estimates of $177.23 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. On average, equities analysts forecast that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Avanos Medical from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

Insider Transactions at Avanos Medical

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the firm's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the transaction, the senior vice president now directly owns 82,047 shares of the company's stock, valued at approximately $1,251,216.75. This trade represents a 7.86 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 2.64% of the company's stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.